{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fquadshot-news-podcast.simplecast.com%2Fepisodes%2F4152024-checkpoint-_zHhRGy9","width":444,"version":"1.0","type":"rich","title":"4.15.2024 - Checkpoint","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/d4956b26-f7a3-4f47-a83d-9293649d65c8/ec08e780-4e06-4c01-8109-4e894d682296/qs_sqaure.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/ee1c676e-2e9a-42b0-bb35-d000bfc21f2d\" height=\"200\" width=\"100%\" title=\"4.15.2024 - Checkpoint\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Check out this week's episode of the QuadCast where we highlight the PFS benefit of pembro in cervical cancer, the benefit of adjuvant RT in thymic carcinoma, a novel agent for GBM, and a handy calculator for re-irradiation."}